- Home
- RVSB vs TIL Comparison
RVSB vs TIL Comparison
Compare RVSB & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- TIL
- Stock Information
- Founded
- RVSB 1923
- TIL 2018
- Country
- RVSB United States
- TIL United States
- Employees
- RVSB N/A
- TIL N/A
- Industry
- RVSB Savings Institutions
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- TIL Health Care
- Exchange
- RVSB Nasdaq
- TIL Nasdaq
- Market Cap
- RVSB 115.6M
- TIL 230.1M
- IPO Year
- RVSB 1993
- TIL 2021
- Fundamental
- Price
- RVSB $5.75
- TIL $28.50
- Analyst Decision
- RVSB Buy
- TIL Buy
- Analyst Count
- RVSB 1
- TIL 5
- Target Price
- RVSB $7.00
- TIL $119.00
- AVG Volume (30 Days)
- RVSB 240.3K
- TIL 349.6K
- Earning Date
- RVSB 07-24-2025
- TIL 08-12-2025
- Dividend Yield
- RVSB 1.39%
- TIL N/A
- EPS Growth
- RVSB 27.97
- TIL N/A
- EPS
- RVSB 0.23
- TIL N/A
- Revenue
- RVSB $50,239,000.00
- TIL N/A
- Revenue This Year
- RVSB $12.68
- TIL N/A
- Revenue Next Year
- RVSB $11.53
- TIL N/A
- P/E Ratio
- RVSB $25.00
- TIL N/A
- Revenue Growth
- RVSB 3.95
- TIL N/A
- 52 Week Low
- RVSB $3.30
- TIL $9.62
- 52 Week High
- RVSB $6.59
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- RVSB 60.74
- TIL 52.42
- Support Level
- RVSB $5.47
- TIL $20.60
- Resistance Level
- RVSB $5.85
- TIL $31.67
- Average True Range (ATR)
- RVSB 0.17
- TIL 3.88
- MACD
- RVSB 0.05
- TIL -1.08
- Stochastic Oscillator
- RVSB 81.48
- TIL 42.47
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.